Topical beta‐blockers in dermatologic therapy

An increasing use of beta‐blockers in dermatology has been described over the last 10 years, despite the fact that their use in diseases other than infantile hemangiomas is off‐label. This review discusses the emerging role of topical beta‐blockers in the treatment of infantile hemangioma, but also...

Descripción completa

Detalles Bibliográficos
Autores principales: Filoni, Angela, Ambrogio, Francesca, De Marco, Aurora, Pacifico, Alessia, Bonamonte, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459235/
https://www.ncbi.nlm.nih.gov/pubmed/34075667
http://dx.doi.org/10.1111/dth.15016
_version_ 1784571477988737024
author Filoni, Angela
Ambrogio, Francesca
De Marco, Aurora
Pacifico, Alessia
Bonamonte, Domenico
author_facet Filoni, Angela
Ambrogio, Francesca
De Marco, Aurora
Pacifico, Alessia
Bonamonte, Domenico
author_sort Filoni, Angela
collection PubMed
description An increasing use of beta‐blockers in dermatology has been described over the last 10 years, despite the fact that their use in diseases other than infantile hemangiomas is off‐label. This review discusses the emerging role of topical beta‐blockers in the treatment of infantile hemangioma, but also pyogenic granuloma, Kaposi sarcoma, wounds and nail paronychia. Data in literature demonstrate that topical beta‐blockers are a safe and valid therapeutic option in numerous cutaneous diseases. Side effects are mainly restricted to the application site. Further studies and randomized trials may contribute to reinforce the role of topical beta‐blockers in the dermatological armamentarium.
format Online
Article
Text
id pubmed-8459235
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-84592352021-09-28 Topical beta‐blockers in dermatologic therapy Filoni, Angela Ambrogio, Francesca De Marco, Aurora Pacifico, Alessia Bonamonte, Domenico Dermatol Ther Review Articles An increasing use of beta‐blockers in dermatology has been described over the last 10 years, despite the fact that their use in diseases other than infantile hemangiomas is off‐label. This review discusses the emerging role of topical beta‐blockers in the treatment of infantile hemangioma, but also pyogenic granuloma, Kaposi sarcoma, wounds and nail paronychia. Data in literature demonstrate that topical beta‐blockers are a safe and valid therapeutic option in numerous cutaneous diseases. Side effects are mainly restricted to the application site. Further studies and randomized trials may contribute to reinforce the role of topical beta‐blockers in the dermatological armamentarium. John Wiley & Sons, Inc. 2021-06-21 2021 /pmc/articles/PMC8459235/ /pubmed/34075667 http://dx.doi.org/10.1111/dth.15016 Text en © 2021 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Filoni, Angela
Ambrogio, Francesca
De Marco, Aurora
Pacifico, Alessia
Bonamonte, Domenico
Topical beta‐blockers in dermatologic therapy
title Topical beta‐blockers in dermatologic therapy
title_full Topical beta‐blockers in dermatologic therapy
title_fullStr Topical beta‐blockers in dermatologic therapy
title_full_unstemmed Topical beta‐blockers in dermatologic therapy
title_short Topical beta‐blockers in dermatologic therapy
title_sort topical beta‐blockers in dermatologic therapy
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459235/
https://www.ncbi.nlm.nih.gov/pubmed/34075667
http://dx.doi.org/10.1111/dth.15016
work_keys_str_mv AT filoniangela topicalbetablockersindermatologictherapy
AT ambrogiofrancesca topicalbetablockersindermatologictherapy
AT demarcoaurora topicalbetablockersindermatologictherapy
AT pacificoalessia topicalbetablockersindermatologictherapy
AT bonamontedomenico topicalbetablockersindermatologictherapy

Ejemplares similares